Seeking AlphaWed, 13 May 2026 19:00:55 GMTBicara Therapeutics Inc. (BCAX) Presents at Bank of America Global Healthcare Conference 2026 TranscriptBCAX-6.21%
Seeking AlphaMon, 11 May 2026 16:00:44 GMTBicara Therapeutics Inc. (BCAX) Q1 2026 Earnings Call TranscriptBCAX-6.21%
Zacks Investment ResearchWed, 01 Apr 2026 14:55:17 GMTWall Street Analysts Believe Bicara Therapeutics Inc. (BCAX) Could Rally 54.85%: Here's is How to TradeBCAX-6.21%
Seeking AlphaTue, 31 Mar 2026 19:34:27 GMTBicara: Maintaining 'Buy' Rating On Ficerafusp Alfa Phase 3 AdvancementBCAX-6.21%
Seeking AlphaMon, 30 Mar 2026 16:32:04 GMTBicara Therapeutics Inc. (BCAX) Q4 2025 Earnings Call TranscriptBCAX-6.21%
The Motley FoolMon, 30 Mar 2026 16:21:45 GMTBicara Therapeutics CEO Sold Over 8,000 Company Shares. Is the Stock a Sell or Buy?BCAX-6.21%
The Motley FoolThu, 26 Mar 2026 21:28:28 GMTBicara Therapeutics CEO Quietly Sold Shares. Her 339,000-Share Stake Speaks Louder.BCAX-6.21%
Seeking AlphaTue, 10 Mar 2026 22:50:16 GMTBicara Therapeutics Inc. (BCAX) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptBCAX-6.21%
Seeking AlphaWed, 25 Feb 2026 20:38:03 GMTBicara Therapeutics Inc. (BCAX) Discusses Ficerafusp Alfa Clinical Data and Less Frequent Dosing in First-Line HPV-Negative Head and Neck Squamous Cell Carcinoma TranscriptBCAX-6.21%
